Prescription Required
Inclusive of all taxes
In Nutritional deficiencies Recalvin 137.5mg/5000IU/50mcg Injection is a calcium supplement that helps in the treatment of calcium deficiency. Recalvin 137.5mg/5000IU/50mcg Injection also has vitamin D3 which is important for the absorption of calcium and helps regulate the amount of calcium and phosphate in your body. This helps in the growth and development of bones as well as reduces the risk of bone disorders like osteoporosis. Recalvin 137.5mg/5000IU/50mcg Injection is also necessary for normal functioning of nerves, cells, muscle and heart.
It is unsafe to consume alcohol with Recalvin 137.5mg/5000IU/50mcg Injection.
Recalvin 137.5mg/5000IU/50mcg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Recalvin 137.5mg/5000IU/50mcg Injection is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Recalvin 137.5mg/5000IU/50mcg Injection does not usually affect your ability to drive.
Recalvin 137.5mg/5000IU/50mcg Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Recalvin 137.5mg/5000IU/50mcg Injection may not be needed in these patients. Please consult your doctor.
Recalvin 137.5mg/5000IU/50mcg Injection is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Recalvin 137.5mg/5000IU/50mcg Injection may not be needed in these patients. Please consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Marc Laboratories Pvt Ltd || ₹14.5/tablet (25% cheaper)